BIO-key Regains Nasdaq Compliance; Trading to Resume July 8

BIO-key announced Nasdaq will resume trading its common stock effective July 8 after regaining compliance.

Key Highlights:

• Nasdaq notified BIO-key that trading of its common stock will recommence at market open on July 8, 2026.
• Restoration follows a June 16 Nasdaq Hearings Panel decision that the company regained compliance with listing standards.
• Compliance included meeting minimum bid price and SEC filing requirements, enabling relisting.
• BIO-key will be subject to a Discretionary Panel Monitor under Nasdaq Rule 5815(d)(4)(B) through July 6, 2027.
• Company cites growing recurring revenue, stronger financial position, and streamlined costs as drivers for improved results.

Original SEC Filing:

This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.